Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study

de Boer, 2020, Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment, Kidney Int, 98, 839, 10.1016/j.kint.2020.06.024 Afkarian, 2013, Kidney disease and increased mortality risk in type 2 diabetes, J Am Soc Nephrol, 24, 302, 10.1681/ASN.2012070718 Yeh, 2020, Temporal trends of incident diabetes mellitus and subsequent outcomes in patients receiving kidney transplantation: a national cohort study in Taiwan, Diabetol Metab Syndr, 12, 34, 10.1186/s13098-020-00541-3 United States Renal Data System. 2019 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2019. 2019 Leung, 2015, Renal registry in Hong Kong—the first 20 years, Kidney Int Suppl, 5, 33, 10.1038/kisup.2015.7 Thomas, 2016, Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease, Nat Rev Nephrol, 12, 73, 10.1038/nrneph.2015.173 Harding, 2019, Global trends in diabetes complications: a review of current evidence, Diabetologia, 62, 3, 10.1007/s00125-018-4711-2 Gregg, 2019, Resurgence in diabetes-Related complications, JAMA, 321, 1867, 10.1001/jama.2019.3471 Burrows, 2010, Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline, Diabetes Care, 33, 73, 10.2337/dc09-0343 Narres, 2020, Incidence and relative risk of renal replacement therapy in people with and without diabetes between 2002 and 2016 in a German region, Diabetologia, 63, 648, 10.1007/s00125-019-05067-6 Koye, 2019, Trends in incidence of ESKD in people with type 1 and type 2 diabetes in Australia, Am J Kidney Dis, 73, 300, 10.1053/j.ajkd.2018.10.005 Hong Kong Hospital Authority. Hospital Authority Annual Report 2018-2019. 2020. https://www.ha.org.hk/visitor/ha_visitor_index.asp?Content_ID=253826&Lang=ENG (accessed 19 November 2020). Luk, 2020, Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study, PLoS Med, 17, 10.1371/journal.pmed.1003052 Ke, 2019, Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study, Ann Intern Med, 170, 145, 10.7326/M18-1900 Wu, 2020, Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study, Diabetologia, 63, 757, 10.1007/s00125-019-05074-7 Wu, 2020, Secular trends in rates of hospitalisation for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study, Diabetologia, 63, 2689, 10.1007/s00125-020-05278-2 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Levey, 2020, Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference, Kidney Int, 97, 1117, 10.1016/j.kint.2020.02.010 Stevens, 2013, Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline, Ann Intern Med, 158, 825, 10.7326/0003-4819-158-11-201306040-00007 Saeedi, 2019, Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, Diabetes Res Clin Pract, 157, 10.1016/j.diabres.2019.107843 Wu, 2020, Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study, Cardiovasc Diabetol, 19, 60, 10.1186/s12933-020-01039-y Luk, 2021, Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study, Diabetologia, 64, 109, 10.1007/s00125-020-05286-2 Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z Gregg, 2014, Changes in diabetes-related complications in the United States, 1990-2010, N Engl J Med, 370, 1514, 10.1056/NEJMoa1310799 Andersen, 2017, Life years lost among patients with a given disease, Stat Med, 36, 3573, 10.1002/sim.7357 Plana-Ripoll, 2019, A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study, Lancet, 394, 1827, 10.1016/S0140-6736(19)32316-5 Erlangsen, 2017, Cause-specific life-years lost in people with mental disorders: a nationwide, register-based cohort study, Lancet Psychiatry, 4, 937, 10.1016/S2215-0366(17)30429-7 Plana-Ripoll, 2020, lillies: An R package for the estimation of excess Life Years Lost among patients with a given disease or condition, Plos One, 15, 1, 10.1371/journal.pone.0228073 Andersen, 2013, Decomposition of number of life years lost according to causes of death, Stat Med, 32, 5278, 10.1002/sim.5903 Luk, 2019, Diabetes-related complications and mortality in patients with young-onset latent autoimmune diabetes: a 14-year analysis of the prospective Hong Kong Diabetes Register, Diabetes Care, 42, 1042, 10.2337/dc18-1796 Luk, 2014, Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes, Diabetes Care, 37, 149, 10.2337/dc13-1336 Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161 Yang, 2020, Trends in glucose-lowering drug use, glycemic control, and severe hypoglycemia in adults with diabetes in Hong Kong, 2002-2016, Diabetes Care, 43, 2967, 10.2337/dc20-0260 Wan, 2018, Five-year effectiveness of the multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on diabetes-related complications and health service uses—a population-based and propensity-matched cohort study, Diabetes Care, 41, 49, 10.2337/dc17-0426 Chan, 2019, Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 96, 37, 10.1016/j.kint.2019.01.017 Liyanage, 2015, Worldwide access to treatment for end-stage kidney disease: a systematic review, Lancet, 385, 1975, 10.1016/S0140-6736(14)61601-9 International Registry in Organ Donation and Transplantation, 2020. https://www.irodat.org/?p=database&c=_H&year=2015#data (accessed 3 March 2021). United States Renal Data System, 2013 USRDS annual data report, Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013. Kramer, 2016, Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus, Clin Kidney J, 9, 457, 10.1093/ckj/sfv151 Yeung, 2014, Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort, Lancet Diabetes Endocrinol, 2, 935, 10.1016/S2213-8587(14)70137-8 Tonelli, 2011, Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes, Am J Transplant, 11, 2093, 10.1111/j.1600-6143.2011.03686.x Stevens, 2011, Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities, Kidney Int, 79, 555, 10.1038/ki.2010.462